针对M.结核菌蛋白酶体核心颗粒的全调节的结构基础
Madison Turner1, Adwaith B Uday2, Algirdas Velyvis1
1Department of Molecular and Cellular Biology, University of Guelph, Guelph, Ontario, Canada.
Nature communications
|April 1, 2025
概括
研究人员发现了一种新的方法,即Mycobacterium结核病蛋白酶抑制自身. 这一发现为开发结核病治疗方法提供了一种新的策略,通过向全卵性调节来治疗结核病.
科学领域:
- 生物化学 生物化学
- 结构生物学 结构生物学
- 微生物学 微生物学
背景情况:
- 结核菌菌 (Mtb) 蛋白酶体系统通过降解受损蛋白质,对病原体的生存至关重要.
- 准mtb 20S蛋白酶体核心粒子 (CP) 是结核病治疗的一个有前途的策略.
- 已知Mtb 20S CP的整体调节,但其结构基础尚不清楚.
研究的目的:
- 为了确定在自动抑制状态下Mtb 20S CP的高分辨率结构.
- 阐明Mtb 20S CP中全性调节的结构机制.
- 探索针对抗结核药物开发的向全位的潜力.
主要方法:
- 使用单粒子电子冷显微镜 (cryo-EM) 来确定Mtb 20S CP结构.
- -交换质谱 (HDX-MS) 提供了对蛋白质动态的洞察力.
- 进行了生化实验,以评估Mtb 20S CP活性和全调节.
主要成果:
- 这项研究确定了Mtb 20S CP在自抑制构造中的结构.
- 观察到在α/β接口上的开关螺旋的重新排列,导致S1口袋的崩和基质结合的抑制.
- 生物化学测试证实,Mtb 20S CP活性可以通过远离活性部位的全位调节.
结论:
- 这些发现揭示了Mtb 20S CP.的新型自抑制形状.
- 了解全卵性调节的结构基础为治疗干预提供了新的途径.
- 向全位是开发新型抗结核药物的有希望的策略.
更多相关视频
09:57Examining Proteasome Assembly with Recombinant Archaeal Proteasomes and Nondenaturing PAGE: The Case for a Combined Approach
Published on: December 17, 2016
6.6K
09:57System for Efficacy and Cytotoxicity Screening of Inhibitors Targeting Intracellular Mycobacterium tuberculosis
Published on: April 5, 2017
8.5K
相关概念视频
Allosteric Regulation
57.2K
Allosteric regulation of enzymes occurs when the binding of an effector molecule to a site that is different from the active site causes a change in the enzymatic activity. This alternate site is called an allosteric site, and an enzyme can contain more than one of these sites. Allosteric regulation can either be positive or negative, resulting in an increase or decrease in enzyme activity. Most enzymes that display allosteric regulation are metabolic enzymes involved in the degradation or...
57.2K
Allosteric Proteins-ATCase
5.6K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
5.6K
Covalently Linked Protein Regulators
6.7K
Proteins can undergo many types of post-translational modifications, often in response to changes in their environment. These modifications play an important role in the function and stability of these proteins. Covalently linked molecules include functional groups, such as methyl, acetyl, and phosphate groups, and also small proteins, such as ubiquitin. There are around 200 different types of covalent regulators that have been identified.
These groups modify specific amino acids in a protein....
These groups modify specific amino acids in a protein....
6.7K
Ligand Binding and Linkage
4.7K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
4.7K
Cooperative Allosteric Transitions
7.8K
Cooperative allosteric transitions can occur in multimeric proteins, where each subunit of the protein has its own ligand-binding site. When a ligand binds to any of these subunits, it triggers a conformational change that affects the binding sites in the other subunits; this can change the affinity of the other sites for their respective ligands. The ability of the protein to change the shape of its binding site is attributed to the presence of a mix of flexible and stable segments in the...
7.8K
The Proteasome Structure
653
The ubiquitin-proteasome pathway is a well-known mechanism utilized by eukaryotic cells to remove cytoplasmic proteins that are misfolded, damaged, or no longer needed. In this pathway, the protein that needs to be eliminated undergoes a process called ubiquitination, where a chain of ubiquitin molecules is attached to the 48th lysine residue of the target protein. This ubiquitin modification helps the proteasome distinguish between a target protein and a healthy protein.
The proteasome is an...
The proteasome is an...
653
